Purchases and Sales Made in Q3 2024 in Syndax Pharmaceuticals Inc (SNDX)
This table provides information about the institutional ownership of Syndax Pharmaceuticals Inc (SNDX) during Q3 2024. The information is specifically focused on institutions that hold shares of Syndax Pharmaceuticals Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Lion Point Capital, LP
New York, NY |
SELL
|
- |
-18.8K- 28.92% |
$337K - $466K
|
46.2K
$650K
|
|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-19.7K- 43.71% |
$353K - $489K
|
25.4K
$357K
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-19.8K- 12.9% |
$354K - $490K
|
134K
$1.88M
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-21K- 18.99% |
$376K - $520K
|
89.5K
$1.26M
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-22.5K- 32.0% |
$403K - $557K
|
47.7K
$672K
|
|
|
Nov 01, 2024
Q3 2024
|
Strs Ohio
|
SELL
|
- |
-22.8K- 80.85% |
$409K - $566K
|
5.4K
$76K
|
|
|
Nov 12, 2024
Q3 2024
|
Fox Run Management, L.L.C.
Greenwich, CT |
SELL
|
- |
-25.9K- 46.35% |
$464K - $642K
|
30K
$422K
|
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-34.9K- 6.69% |
$625K - $865K
|
486K
$6.85M
|
|
|
Nov 14, 2024
Q3 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-42.4K- 4.93% |
$760K - $1.05M
|
818K
$11.5M
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-44.5K- 4.78% |
$797K - $1.1M
|
886K
$12.5M
|
|
|
Nov 12, 2024
Q3 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-60.5K- 64.4% |
$1.08M - $1.5M
|
33.4K
$471K
|
|
|
Nov 14, 2024
Q3 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-65.2K- 45.12% |
$1.17M - $1.62M
|
79.3K
$1.12M
|
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-73.4K- 28.14% |
$1.32M - $1.82M
|
187K
$2.64M
|
|
|
Nov 14, 2024
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-89.5K- 48.72% |
$1.6M - $2.22M
|
94.2K
$1.33M
|
|
|
Nov 14, 2024
Q3 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-92.4K- 15.38% |
$1.66M - $2.29M
|
508K
$7.16M
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-94.9K- 11.14% |
$1.7M - $2.35M
|
757K
$10.7M
|
|
|
Nov 13, 2024
Q3 2024
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-96.1K- 71.52% |
$1.72M - $2.39M
|
38.3K
$539K
|
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-96.9K- 17.41% |
$1.74M - $2.4M
|
460K
$6.47M
|
|
|
Nov 14, 2024
Q3 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-130K- 19.84% |
$2.34M - $3.23M
|
527K
$7.42M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-156K- 82.09% |
$2.8M - $3.87M
|
34K
$479K
|
|
|
Nov 14, 2024
Q3 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-157K- 30.27% |
$2.82M - $3.9M
|
362K
$5.09M
|
|
|
Nov 14, 2024
Q3 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-198K- 69.87% |
$3.56M - $4.92M
|
85.5K
$1.2M
|
|
|
Nov 12, 2024
Q3 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-307K- 49.12% |
$5.51M - $7.62M
|
318K
$4.48M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-841K- 45.92% |
$15.1M - $20.9M
|
990K
$13.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-880K- 26.39% |
$15.8M - $21.8M
|
2.46M
$34.6M
|
|
|
Nov 13, 2024
Q3 2024
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-1.37M- 63.46% |
$24.5M - $33.9M
|
787K
$11.1M
|
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-2.35M- 32.06% |
$42.2M - $58.4M
|
4.99M
$70.2M
|